Integrum announces appointment of Jörgen Svanström as interim CFO
Mölndal, Sweden – May 2, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has appointed Jörgen Svanström as interim Chief Finance Officer.
Jörgen Svanström has broad experience as a financial consultant and from the tech sector, most recently as interim Director of Administrative Services Europe at Fingerprint Cards. Former positions include Business Controller at Greencarrier Liner Agency, Financial Manager at Mediatec Solutions Sweden and Financial Controller at Maersk Sverige.
“We are happy to welcome Jörgen Svanström as interim CFO while the process to find a permanent solution continues,” said Rickard Brånemark, MD, PhD, orthopedic surgeon, CEO and founder of Integrum.
For more information please contact:
Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: rickard.branemark@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.
ABOUT INTEGRUM
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA™ Implant System has helped improve the quality of life for hundreds of people who are amputees by directly attaching a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA™ System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use in amputees available in the U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/.